https://www.selleckchem.com/products/sbe-b-cd.html
1%. Upper forehead VAS (7.9 ± 1.2) was not different than lower forehead VAS (7.9 ± 1.2) regardless of treatment (P = 0.62). The VAS score of BTX-A-treated scars (8.5 ± 1. was significantly higher than the control (7.3 ± 1.1; P 0.0001). Among 104 individual comparisons (26 patients × 4 observers), there were 73 instances (70.2%) where the experimental VAS score was higher than the control. Preoperative BTX-A injection is feasible and enhances donor site scar appearance after forehead flap nasal reconstruction in an Asian populat
Like
Comment
Share
